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Case ReportsDemonstration of the skip metastasis pathway for N2 non–small cell
lung cancerHiromitsu Takizawa, MD, Shoji Sakiyama, MD, Mitsuhiro Tsuboi, MD, and Akira Tangoku, MD,
Tokushima, JapanWe report the use of an indocyanine green (ICG)–near-
infrared fluorescence (NIF) imaging system for the
intraoperative detection of lung cancer metastasis directlyFIGURE 1. Intraoperative endoscopic findings. A, A 2-mL dose of indocyanin
needle. B, White-light mode showing injected indocyanine green. C, Indocyan
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e50 The Journal of Thoracic and Cardiovascular Surgto mediastinal lymph nodes without intrapulmonary or hilar
lymph node involvement (skip metastasis).CLINICAL SUMMARY
A 67-year-old woman whose chest computed tomo-
graphic scan images showed a 23-mm solid tumor
in the right segment 7 without any lobar, hilar, or medias-
tinal lymphadenopathy was referred to our hospital.
Transbronchial endoscopic tumor biopsy revealed the
tumor to be an adenocarcinoma. Positron emission
tomographic and computed tomographic imaging with
fludeoxyglucose F 18 (INN fludeoxyglucose [18F])
showed no marker uptake in any lymph nodes and no
distant metastases. Postcontrast magnetic resonance
imaging of the brain also indicated no brain metastases.e green was injected into the peritumoral lung parenchyma with a 26-gauge
ine green mode showing fluorescence of injection site.
ery c April 2014
FIGURE 2. Intraoperative endoscopic findings. A, White-light mode showing subcarinal lymph nodes. C, Indocyanine green mode showing 2 subpleural
lymphatic vessels and a sentinel node, all of which were illuminated by indocyanine green. C and D, Magnified views of panels A and B, respectively.
RLL, Right lower lobe.
Case ReportsThe diagnosis of clinical T1b N0 M0, stage IA non–small
cell lung cancer (NSCLC) was made, and the patient
underwent video-assisted thoracic surgical (VATS) right
lower lobectomy with standard mediastinal lymph node
dissection.
In our hospital, a clinical study to identify sentinel nodes
(SNs) in patients with NSCLC during VATS lobectomy
or segmentectomy by means of an indocyanine green
fluorescence endoscopy system is ongoing. This patient
was enrolled in that study.
After exploration of the thoracic cavitywith an endoscope
before VATS lobectomy, 2 mL of ICG was injected into the
peritumoral lung parenchyma (Figure 1,A-C). After the right
lung had beenventilated for 3minutes to stimulate lymphatic
flow, the hilum, intralobar area, and mediastinum were
observed with an endoscopic ICG-NIF imaging system
(D-LIGHT P; Karl Storz GmbH & Co KG, Tuttlingen, Ger-
many). Two subpleural lymphatic vessels running toward the
subcarinal lymph node station were clearly visualized by the
ICG mode, and 1 of the vessels reached a lymph node that
was also illuminated by ICG (Figure 2, A-D). Other
lymphatic vessels or other lymph nodes did not show ICG
fluorescence. The illuminated lymph node was sampled as
an SN, and other lymph nodes were dissected en bloc.
VATS right lower lobectomy with ND2a-2 lymph node
dissectionwas completed uneventfully. Pathologic examina-
tionwith hematoxylin and eosin staining revealedmetastatic
adenocarcinoma in the SN.Micrometastases were present in
2 of 6 lymph nodes in station 7 and 2 of 15 lymph nodes in
station 4R , although the lobar and hilar lymph nodesThe Journal of Thoracic and Ca(stations 11, 12, and 13) showed no metastasis. The patient
thus was considered to have skip N2 metastasis.
DISCUSSION
Lung cancer often metastasizes directly to mediastinal
lymph nodes without intrapulmonary or hilar lymph node
involvement. This phenomenon is called skip metastasis.
Patients with skip metastasis had been reported to be a
unique population with a better prognosis than patients
with pN2 intrapulmonary or hilar lymph node involvement.1
Themechanism of skip metastasis has been considered as
follows. First, tumors with visceral pleural involvement
metastasize to mediastinal lymph nodes through lymphatic
vessels of the parietal pleura. Then tumors metastasize to
the mediastinal lymph nodes through intrapulmonary
lymphatic vessels, bypassing the N1 node. Another possible
explanation for skip metastasis may be the failure to
note N1 micrometastasis on routine histopathologic
examination.
In this case, a subpleural lymphatic vessel running toward
one of the subcarinal lymph nodes was clearly visualized
with the endoscopic ICG-NIF imaging system. Pathologic
examination revealed that the SN was a metastatic lymph
node, whereas intrapulmonary and hilar lymph nodes
showed no metastasis. In this skip metastasis case, the tu-
mor was considered to have metastasized to the mediastinal
lymph nodes through lymphatic vessels of the parietal
pleura.
The SN is defined as the first node draining a tumor and
should be the first site affected in lymphatic dissemination.rdiovascular Surgery c Volume 147, Number 4 e51
Case ReportsSN navigation surgery has been commonly performed in
breast cancer surgery to reduce the extent of lymphadenec-
tomy, leading to a reduction in operative complications. On
the other hand, lymphadenectomy has not been found to
increase the operative mortality or complications relative
to lymph node sampling in NSCLC surgery.2
SN identification has a new significance in recent
NSCLC surgery. With the increased incidence of detection
of small-sized NSCLC, a phase III randomized trial of
lobectomy versus segmentectomy for small-sized periph-
eral NSCLC is ongoing.3 The eligibility criteria for segmen-
tectomy state that there should be ‘‘no lymph node
metastasis’’ and that patients with node-positive cases
should undergo lobectomy with standard lymphadenec-
tomy to ensure radical resection. Because the accuracy of
clinical nodal staging even with fludeoxyglucose F18
positron emission tomography and computed tomography
is still low,4 intraoperative sampling and frozen sectioning
of lymph nodes are indispensable for segmentectomy.
Random sampling of N1 lymph nodes has no meaning,
however, because the lymphatic flow of the lung varies.
Therefore, SN identification is important for patients
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imaging system became commercially available, and this
system can be used during VATS.
In conclusion, this report shows the utility of an
endoscopic ICG-NIF imaging system for SN identification
during VATS, with especial value in identifying subpleural
lymphatic spread.
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study. J Thorac Cardiovasc Surg. 2012;144:94-9.Minimally invasive enucleation of a large, extensively calcified
esophageal leiomyoma
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A number of gastrointestinal tumors may present with
macroscopic calcifications; however, true esophagealtumors with this characteristic are uncommon. Leiomyo-
mas are the most likely esophageal neoplasms to develop
calcifications, and the presence of calcification within an
esophageal tumor strongly suggests this diagnosis. We pre-
sent a case of a rare calcified, distal esophageal leiomyoma
that was successfully enucleated through a thoracoscopic
approach.CLINICAL SUMMARY
A 63-year-old man was referred to our institution with
reports of vague left-sided chest pain for the previous
3 months and new-onset atrial fibrillation. A chest radio-
graph suggested a calcified posterior mediastinal mass
(Figure 1, A). Workup continued with a barium esophago-
gram, which demonstrated a large, smooth-bordered, extra-
luminal, partially-obstructing distal esophageal mass
(Figure 1, B). A subsequent computed tomographic scan
of the chest confirmed the intramural, multilobulated,
calcified mass measuring 7 cm in maximum diameterery c April 2014
